CENTER ID: | TogoA.18611.a |
ORGANISM: | Toxoplasma gondii ME49 |
ASSOCIATED DISEASE: | Toxoplasmosis |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
TogoA.18611.a.B2.GE37766 | thioredoxin domains 1 and 2 | 306 | 742 | ||
TogoA.18611.a.B3.GE37767 | N-terminal domain | 55 | 260 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
TogoA.18611.a.B2.PS02016 | thioredoxin domains 1 and 2 | 306 | 742 | unavailable |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | ToxoDB:TGME49_312110 |
RefSeq: | XP_002364433.1 |
UniProt: | B6K8Q9 |
HARVESTED ON: | 2/5/2014 |
SEQUENCED ON: | 2/4/2014 |
EXPECTED MW: | 50kDa |
OBSERVED MW: | 50kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Too many to count (100+) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | data unavailable |
SEQUENCING RESULT: | pass with incomplete coverage |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 45 |
HARVESTED ON: | 2/5/2014 |
SEQUENCED ON: | 2/4/2014 |
EXPECTED MW: | 23kDa |
OBSERVED MW: | 23kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Too many to count (100+) |
TOTAL EXPRESSION LEVEL: | Low Expression |
SOLUBLE EXPRESSION LEVEL | Low Expression |
EXPRESSION HOST: | data unavailable |
SEQUENCING RESULT: | pass with sequence variation |
PERCENT IDENTITY: | 30 |
PERCENT COVERAGE: | 50 |
PURIFICATION DATe: | 3/12/2014 |
CONCENTRATION: | 39mg/ml |
OBSERVED MW: | 50kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP |
EXPRESSION HOST: | data unavailable |
VIAL COUNT (approx.): | data unavailable |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 45 |